IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

all

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 23 Jul 2015 | Removal date: open ended
Still in force

State loan

On July 23, 2015 Brad Butt, Member of Parliament for Mississauga-Streetsville, Ontario announced a support package for Therapure Biopharma.
 
The government is providing a $20 million repayable contribution, under the Advanced Manufacturing Fund initiative, to accelerate the design, development and commercialization of Therapure's PlasmaCap Expanded Bed Absorption technology. The process yields protein from blood.
 
The GTA includes state guarantees and other financial incentives that are likely to affect the restructuring and performance of firms facing international competition, whether from imports, in export markets, and from foreign subsidiaries.

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products
3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micr
300210 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
300220 Vaccines for human medicine
300230 Vaccines for veterinary medicine
300290 Other

Please report this page in case you detect an inaccuracy in its content.